Clinical trial
The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3
NCT00142883 · Yale University, Other · Terminated
Key facts
| NCT number | NCT00142883 |
|---|---|
| Title | The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 |
| Official title | The Effects of GABA Medications on Cocaine Responses in Humans |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Cocaine Abuse, Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Pregabalin, placebo |
| Enrollment | 72 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Jul 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: